CMK Corporation provides consolidated earnings guidance for the full year ending March 31, 2022. For the full year, The company expects net sales to be JPY 79,500 million, Operating income to be JPY 2,800 million, Profit attributable to owners of parent to be JPY 2,000 million or JPY 33.79 per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
588 JPY | +0.86% | -3.76% | -29.16% |
02-28 | Aurora Cannabis Teams Up With Script Assist to Provide Access to UK Medical Cannabis; Down 1.8% | MT |
02-28 | Aurora Cannabis Teams Up With Script Assist to Provide Access to UK Medical Cannabis | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.16% | 251M | |
+18.72% | 58.39B | |
-18.87% | 14.99B | |
+20.70% | 11.57B | |
+28.94% | 9.24B | |
+8.52% | 8.61B | |
+45.34% | 8.48B | |
-8.84% | 8.37B | |
-11.41% | 7.7B | |
-16.83% | 6.7B |
- Stock Market
- Equities
- 6958 Stock
- News CMK Corporation
- CMK Corporation Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2022